Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Biostage, Inc. | v458281_s1a.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Biostage, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
Our report dated March 30, 2016 contains an explanatory paragraph that states that the Company has suffered recurring losses from operations and will require additional financing to fund future operations which raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty.
| /s/ KPMG LLP |
| Cambridge, Massachusetts |
| February 3, 2017 |